速递｜司美格鲁肽骗保被点名！超量购买达2300余天，被暂停医保结算

Core Viewpoint - The article highlights the increasing prevalence of healthcare fraud related to high-value drugs, particularly focusing on the misuse of the drug Semaglutide, which is impacting the integrity of the pharmaceutical market [2]. Group 1: Healthcare Fraud Cases - The National Healthcare Security Administration has reported typical cases of healthcare fraud involving pharmacies and hospitals, with high-value drugs being a major area of concern [2]. - A specific case in Shanghai involved an individual, Niu, who purchased Semaglutide injections excessively over a two-year period, exceeding the standard dosage for diabetes patients by over 800 days [2]. - Niu's parents were also found to have purchased excessive amounts of the same drug, with the father exceeding the standard dosage for over 800 days and the mother for over 700 days [2]. Group 2: Regulatory Actions - The Shanghai healthcare department mandated Niu to refund 23,258.03 yuan and suspended his network settlement for three months, with similar actions taken against his parents [2]. - The investigation revealed issues such as illegal procurement of drugs, lack of proper prescription review, fraudulent invoicing, and excessive prescriptions, which have been referred to law enforcement and health authorities for further action [2].